By becoming accredited in the Medidata Rave electronic data capture (EDC) and clinical data management (CDM) system, LSK can provide a full suite of Rave services to the growing South Korea trial market as well as global sponsors.
"With the strong local support of the Medidata team over the past year, we have increased our ability to successfully provide high-quality services for our sponsor customers," said Young-Jack Lee, president of LSK. "Medidata's global reputation and experience in emerging markets has proven invaluable as Korean pharmas evolve their processes to adhere to new local laws and varying regulations around the world."
As sponsors in the Korean market continue to expand globally, LSK decided to extend its relationship with Medidata around Rave's easy-to-use platform and streamlined processes. The new accreditation enables LSK to serve as a single source for sponsors to acquire all Rave-related services, including end user training, study build, reporting, outputs, integrations and migrations.
"With this accreditation, LSK continues to demonstrate its commitment to providing sponsors with increasing efficiencies across their clinical trials and expertise around both local and global regulations," said Tarek Sherif, CEO of Medidata Solutions. "This achievement further highlights Medidata's expanding global reach, particularly in the growing Asian market."
Medidata first announced its channel partner program in April 2005 to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, the program has grown to include more than 30 partners in the U.S., Europe and Asia, ranging from smaller clinical consultancies to large, global CROs and now offers accreditations for eight Medidata applications in its cloud-based clinical platform.